Literature DB >> 25200255

Guidelines and tools for organizing and conducting maternal death reviews.

Vincent De Brouwere1, Véronique Zinnen2, Thérèse Delvaux2, Robert Leke3.   

Abstract

Maternal death reviews (MDRs) provide the multidisciplinary maternity care team with a process to conduct in-depth review of the health care and circumstances surrounding maternal deaths. From these reviews, recommendations to improve care in primary, secondary, and tertiary healthcare settings can be made. Practical guidelines and training curricula for MDRs are lacking. To fill this gap, a manual comprising guidelines and tools to help health professionals conduct structured MDRs was developed through the FIGO LOGIC initiative.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  FIGO LOGIC initiative; Guidelines; Maternal death review; Quality of care

Mesh:

Year:  2014        PMID: 25200255     DOI: 10.1016/j.ijgo.2014.07.006

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  Maternal mortality audit in Suriname between 2010 and 2014, a reproductive age mortality survey.

Authors:  Lachmi R Kodan; Kim J C Verschueren; Jos van Roosmalen; Humphrey H H Kanhai; Kitty W M Bloemenkamp
Journal:  BMC Pregnancy Childbirth       Date:  2017-08-29       Impact factor: 3.007

2.  Inadequate programming, insufficient communication and non-compliance with the basic principles of maternal death audits in health districts in Burkina Faso: a qualitative study.

Authors:  Boukaré Congo; Djénéba Sanon; Tieba Millogo; Charlemagne Marie Ouedraogo; Wambi Maurice E Yaméogo; Ziemlé Clement Meda; Seni Kouanda
Journal:  Reprod Health       Date:  2017-09-29       Impact factor: 3.223

3.  The golden hour of sepsis: An in-depth analysis of sepsis-related maternal mortality in middle-income country Suriname.

Authors:  Lachmi R Kodan; Kim J C Verschueren; Humphrey H H Kanhai; Jos J M van Roosmalen; Kitty W M Bloemenkamp; Marcus J Rijken
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.